Livzon Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Livzon Pharmaceutical Group Inc (000513)
Livzon Pharmaceutical Group Inc stock price live, this page displays SZ 000513 stock exchange data. View the 000513 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Livzon Pharmaceutical Group Inc real time stock price chart below.
What Is the Livzon Pharmaceutical Group Inc Stock Price Today?
The Livzon Pharmaceutical Group Inc stock price today is 39.65.
What Is the Stock Symbol for Livzon Pharmaceutical Group Inc?
The stock symbol for Livzon Pharmaceutical Group Inc is ""000513.""
What Stock Exchange Does Livzon Pharmaceutical Group Inc Trade On?
Livzon Pharmaceutical Group Inc is listed and trades on the Shenzhen stock exchange.
Is Livzon Pharmaceutical Group Inc a Good Stock to Buy?
Determining whether Livzon Pharmaceutical Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000513 quote. (ISIN: CNE0000002Y8)
What Is the Livzon Pharmaceutical Group Inc Stock Price Today?
The Livzon Pharmaceutical Group Inc stock price today is 39.65.
What Is the Stock Symbol for Livzon Pharmaceutical Group Inc?
The stock symbol for Livzon Pharmaceutical Group Inc is ""000513.""
What Stock Exchange Does Livzon Pharmaceutical Group Inc Trade On?
Livzon Pharmaceutical Group Inc is listed and trades on the Shenzhen stock exchange.
Is Livzon Pharmaceutical Group Inc a Good Stock to Buy?
Determining whether Livzon Pharmaceutical Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000513 quote. (ISIN: CNE0000002Y8)
39.65
-0.65(-1.61%)
Closed·
Fair Value
An estimate of a Livzon Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.60
40.30
52 wk Range
32.94
44.87
000513 Scorecard
Full Analysis
Management has been aggressively buying back shares
000513 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Livzon Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.6040.30
52 wk Range
32.9444.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.77%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.77%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
000513 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Livzon Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
43.31
Upside
+9.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Livzon Pharm A receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Livzon Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Livzon Pharm A receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Livzon Pharmaceutical Group Inc Company Profile
Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China. The company offers Ilaprazole enteric-coated tablets and ilaprazole sodium for injection a series of bismuth potassium citrate products for gastrointestinal field; leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for assisted reproduction field; fluvoxamine maleate and perospirone hydrochloride tablets for psychiatric and neurological field; and shenqi fuzheng injection and anti-viral granules for traditional chinese medicine field. It also produces APIs and intermediates, such as mevastatin, acarbose, phenylalanine, vancomycin hydrochloride, daptomycin, milbemycin oxime, and ceftriaxone sodium; diagnostic reagents such as diagnostic kit for IgM antibody to mycoplasma pneumonia; diagnostic kit for human immunodeficiency virus antibody; and livzon antinuclear antibody test kit. In addition, the company offers nucleic acid test kits; livzon interferon-gamma release assays test kits; diagnostic kit for IgM antibody to mycoplasma pneumonia; influenza A/B virus antigen detection kit; and treponema pallidum antibody detection kit. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics, as well as diagnostic reagents and equipment. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.
Compare 000513 to Peers and Sector
Metrics to compare | 000513 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000513PeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.2x | 25.1x | −0.5x | |
PEG Ratio | 2.07 | 0.12 | 0.00 | |
Price/Book | 2.4x | 2.4x | 2.6x | |
Price / LTM Sales | 2.9x | 3.2x | 3.3x | |
Upside (Analyst Target) | 11.0% | 17.8% | 40.3% | |
Fair Value Upside | Unlock | 14.0% | 4.7% | Unlock |
Analyst Ratings
3 Buy
1 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 43.31
(+9.22% Upside)
Earnings
Latest Release
Apr 23, 2025
EPS / Forecast
0.71 / 0.68
Revenue / Forecast
3.18B / 3.34B
FAQ
What Stock Exchange Does Livzon Pharm A Trade On?
Livzon Pharm A is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Livzon Pharm A?
The stock symbol for Livzon Pharm A is "000513."
What Is the Livzon Pharm A Market Cap?
As of today, Livzon Pharm A market cap is 33.22B.
What Is Livzon Pharm A's Earnings Per Share (TTM)?
The Livzon Pharm A EPS (TTM) is 2.29.
When Is the Next Livzon Pharm A Earnings Date?
Livzon Pharm A will release its next earnings report on 27 Oct 2025.
From a Technical Analysis Perspective, Is 000513 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Livzon Pharm A Stock Split?
Livzon Pharm A has split 6 times.
How Many Employees Does Livzon Pharm A Have?
Livzon Pharm A has 9067 employees.
What is the current trading status of Livzon Pharm A (000513)?
As of 14 Aug 2025, Livzon Pharm A (000513) is trading at a price of 39.65, with a previous close of 40.30. The stock has fluctuated within a day range of 39.60 to 40.30, while its 52-week range spans from 32.94 to 44.87.
What Is Livzon Pharm A (000513) Price Target According to Analysts?
The average 12-month price target for Livzon Pharm A is CNY43.306, with a high estimate of CNY53.17 and a low estimate of CNY33.2. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +9.22% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.